Medpace

Upon their return from AUGS PFD Week, Medpace Women’s Health experts Beth Tulip, Rujin J., and Aparna D. Shah, MD, FACOG, highlighted several significant advancements in #womenshealth clinical research. Discover the latest breakthroughs in women's health — including clinical advancements in personalized medicine, sexual health, essential endpoints, and #FemTech in our latest blog: https://lnkd.in/gD5EiWN3

"First days can be overwhelming, but the team is excited to have you there so take full advantage of the opportunity ahead!" shares Medpace Recruiter Ashley Neugebauer. In our latest blog, discover Ashley's expert tips on making the most of—and celebrating—your first day at #Medpace in our latest blog: https://bit.ly/40TRwRe #WorkAtMedpace

Connect with Dr. Mariko DeWire-Schottmiller at #SNO2024 in Houston, Texas from November 21-24. Dr. DeWire-Schottmiller, a board-certified hematologist and oncologist, brings over a decade of expertise in neuro-oncology, with deep experience spanning clinical research, academia, and oncology practice. With a track record of successfully managing intricate Phase I-IV #hematology and #oncology trials in over 45 countries, we hold the medical leadership, trained staff, global experience, and site relationships in place to make your study a success. Your next breakthrough starts at SNO—schedule a meeting with Dr. DeWire-Schottmiller today: https://lnkd.in/gCfb9JBq

Medpace is ready to partner with leading biopharmaceutical innovators at #ASH2024! As a leader in hematologic clinical development, we bring unparalleled expertise and an embedded, full-service model designed to streamline complex studies and accelerate breakthroughs. 📆 Let’s turn your vision into impactful therapies. Tap the link below to secure a meeting with our attending #hematology experts: https://lnkd.in/ggtWHABf

Today, Medpace joins the global community in recognizing #WorldDiabetesDay, a critical reminder of the growing impact of this chronic disease. Despite years of clinical progress, diabetes continues to pose significant health challenges, with projections showing that 1 in 8 adults will be living with diabetes by 2045. To overcome these health challenges, recent innovations are reshaping how we manage, monitor, and treat diabetes. In this edition of Seamless Clinical Insights, we explore key trends driving breakthroughs in #diabetes clinical research. #Subscribe to our newsletter to gain insights into the latest clinical development trends.

Medpace is thrilled to partner with the University of Cincinnati for the third consecutive year! Seven outstanding UC student-athletes are joining us at #MedpaceAthletes for the 2024-2025 academic year, and we're proud to support their journey both on and off the field. As a company dedicated to the Cincinnati community, we look forward to continuing our sponsorship with UC, in addition to highlighting career opportunities for recent and upcoming graduates. Want to join an #EliteTeam? Browse our career opportunities today: https://bit.ly/3Cpn4Er

In a recently released whitepaper, Dr. Mariko DeWire-Schottmiller explores the common obstacles faced in neuro-oncology clinical trials, recent breakthroughs, and the future of oncology clinical research, including enhanced accessibility and improved outcomes for patients with CNS tumors. Access the on-demand whitepaper today: https://lnkd.in/gZD7utxX Attending #SNO2024? Request a meeting with neuro-oncology expert, Dr. DeWire-Schottmiller to discuss your upcoming neuro-oncology clinical development.

Don't miss out—applications for Medpace's 2025 Spring & Summer #internships are closing soon! Gain hands-on experience in fields like IT, computer science, and more. Apply today: https://bit.ly/3O5Eb0u #WorkAtMedpace

In this new video, Amy Stabler and Britania O'Brien explore key aspects of our infectious diseases and vaccines clinical operations team in North America, which specializes in the design and execution of global trials for antivirals, antibacterials, antifungals, vaccines, and immunotherapies. In the past 7 years, Medpace ID&V experts have contributed to over 90% of antibacterial FDA approvals, 66% of antifungal FDA approvals, and nearly 33% of antiviral FDA approvals. Learn more about Medpace's clinical development capabilities in #InfectiousDiseases and #Vaccines: https://lnkd.in/g-Z8FfPd

It's not too late to secure your spring or summer #internship! Medpace is seeking students with backgrounds in life science to join the Medpace internship program. Apply now to start learning from the brightest minds in biotech: https://bit.ly/48EfPo0 Students with #IT backgrounds—stay tuned for upcoming opportunities! #WorkAtMedpace